| StemCells announced that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC purified human neural stem cells in Pelizaeus-Merzbacher Disease, a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco Children’s Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery. :theflyonthewall.com |
